Idarubicin hydrochloride is an anthracycline antineoplastic agent primarily utilized in the treatment of various cancers, including acute myeloid leukemia, acute lymphoblastic leukemia, and osteosarcoma.… Read more


Idarubicin hydrochloride is an anthracycline antineoplastic agent primarily utilized in the treatment of various cancers, including acute myeloid leukemia, acute lymphoblastic leukemia, and osteosarcoma. This compound functions as a topoisomerase II inhibitor, intercalating into DNA to disrupt replication and transcription processes in cancer cells. The product list within this category provides essential reference standards, including the active pharmaceutical ingredient, process-related impurities, related aglycones, metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories utilize these materials for rigorous impurity profiling, method validation, and ongoing quality control of the drug substance. By supporting precise analytical testing, these reference standards ensure that drug products meet stringent safety and efficacy standards throughout the development and manufacturing lifecycle.
